NDC 87625-103 - SurviveX Travel Med MOD
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 87625-103
- Manufacturer
- Intent Brands LLC
- Effective date
- 2026-08-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SurviveX Travel Med MOD - Intent Brands LLC | Intent Brands LLC | 2026-08-04 | HUMAN OTC DRUG LABEL |
| SurviveX Travel Med Kit - Intent Brands LLC | Intent Brands LLC | 2026-05-07 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| B05 GLUCO BALANCE | ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM | Apex Energetics Inc. | bae9ff7e-eb69-c61d-e053-2995a90a2627 | 2024-01-08 | Warnings | J2B2A4N98G |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | ACETAMINOPHEN AND CODEINE PHOSPHATE | Clinical Solutions Wholesale, LLC | 331d92ac-7287-47c7-b573-b5e6cd58c981 | 2024-01-08 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| N03 EXCHEM | ALLIUM SATIVUM, ARSENICUM ALBUM, BENZOICUM ACIDUM, BERBERIS VULGARIS, BETULA VERRUCOSA, CALCAREA CARBONICA, CARBOLICUM ACIDUM, CHELIDONIUM MAJUS, CHLORINUM, CITRICUM ACIDUM, HISTAMINUM, ICHTHYOLUM, JUNIPERUS COMMUNIS, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM BICARBONICUM, SODIUM HYPOCHLORITE, SOLIDAGO VIRGAUREA, SULPHUR | Apex Energetics Inc. | ba73a050-9a5d-1549-e053-2a95a90a62aa | 2024-01-08 | Warnings | XF417D3PSL 8MDF5V39QO |
| dg health ibuprofen | IBUPROFEN | Dolgencorp Inc | 98492b9f-8f48-42dd-b026-c37dcdc5f888 | 2024-01-08 | Warnings | 310965 WK2XYI10QM |
| Banophen | DIPHENHYDRAMINE HCL | A-S Medication Solutions | e1b05e0c-3c61-4e2e-8e6c-ca1ed5bb93cd | 2024-01-08 | Warnings | M012 1049630 TC2D6JAD40 |
| LOW DOSE ASPIRIN | ASPIRIN | A-S Medication Solutions | ee4451c9-4d0f-4373-8f64-fcc1f9dd5856 | 2024-01-05 | Warnings | M013 R16CO5Y76E |
| AXIM DM Max | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | VIVUNT PHARMA LLC | 0e7424ea-461f-5ead-e063-6294a90a41b6 | 2024-01-05 | Warnings | M012 |
| AXIM Night Time - Liquid | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | VIVUNT PHARMA LLC | 0e740063-80d5-c48b-e063-6394a90a3b30 | 2024-01-05 | Warnings | M012 362O9ITL9D |
| AXIM DayTime - Liquid | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | VIVUNT PHARMA LLC | 0e742e10-daea-6443-e063-6294a90ab5af | 2024-01-05 | Warnings | M012 362O9ITL9D |
| Diphenhydramine HCl | DIPHENHYDRAMINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 3c3e0dc8-cddd-4f46-9b68-19bac00c07cc | 2024-01-05 | Warnings | M012 TC2D6JAD40 |
| Diphenhydramine HCl | DIPHENHYDRAMINE HCL | A-S Medication Solutions | fa12a5a8-bf2d-4991-9d54-9c519e8e04cd | 2024-01-04 | Warnings | M012 TC2D6JAD40 |
| IBUPROFEN CA | IBUPROFEN | TARGET CORPORATION | 8e8684fa-095e-c6d6-e053-2a95a90a15b4 | 2024-01-03 | Warnings | 310965 WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | TARGET CORPORATION | 8e86ae68-7687-79d6-e053-2995a90ac274 | 2024-01-03 | Warnings | 310965 WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | TARGET CORPORATION | 8e8646fe-fd62-1662-e053-2a95a90a3008 | 2024-01-03 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | TARGET CORPORATION | 8e872c8d-28e2-cd49-e053-2995a90a469f | 2024-01-03 | Warnings | 310965 WK2XYI10QM |
| Ibuprofen Mini | IBUPROFEN MINI 200 MG | TARGET CORPORATION | c80426d9-e121-c24d-e053-2a95a90acf2f | 2024-01-03 | Warnings | WK2XYI10QM |
| IBUPROFEN 200 MG | IBUPROFEN | Basic Drugs, Inc. | d3351d44-2078-3adc-e053-2995a90a3c8f | 2024-01-03 | Warnings | ANDA079174 310965 WK2XYI10QM |
| LORATADINE ALLERGY RELIEF 10mg | LORATADINE | YYBA CORP | dcb63e1b-d499-2e84-e053-2995a90af5c7 | 2024-01-03 | Warnings | 311372 7AJO3BO7QN |
| ALLERGY RELIEF 10mg | LORATADINE | YYBA CORP | 6103cf98-40b1-4d27-8eb7-6f6a06949730 | 2024-01-03 | Warnings | 311372 7AJO3BO7QN |
| NASAL DECONGESTANT PE 10mg | PHENYLPHRINE HCL | YYBA CORP | 05824fc4-ef3f-4ebb-b601-252f76ad60ef | 2024-01-03 | Warnings | M012 04JA59TNSJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.